Skip to main content

Peer Review reports

From: Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

Original Submission
11 Dec 2012 Submitted Original manuscript
1 May 2013 Author responded Author comments - Belinda Ha
19 Feb 2013 Reviewed Reviewer Report - Giovanni Guaraldi
6 Mar 2013 Reviewed Reviewer Report - Giustino Parruti
Resubmission - Version 2
1 May 2013 Submitted Manuscript version 2
21 May 2013 Reviewed Reviewer Report - Giustino Parruti
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 May 2013 Editorially accepted
7 Jun 2013 Article published 10.1186/1471-2334-13-269

You can find further information about peer review here.

Back to article page
\